Summary: Using advanced non-linear statistical modeling on a cohort of more than 2,400 older adults, researchers identified a clear curved relationship between nightly sleep duration and levels of phosphorylated tau 181 (p-tau181) in blood. Regularly sleeping about 8.5 hours or more per night was strongly associated with higher plasma p-tau181, a protein closely linked with Alzheimer’s pathology.
The study does not claim that longer sleep causes Alzheimer’s disease. Rather, the findings suggest that extended sleep may be an early behavioral sign of silent neurodegenerative changes in the brain.
Key Facts
- 8.5-hour inflection: Flexible, non-linear models showed that plasma p-tau181 begins to rise noticeably once people report routinely sleeping around 8.5 to 9 hours per night. The increase becomes steep beyond about 10 hours, indicating a marked elevation in this Alzheimer’s-related biomarker.
- Specificity of p-tau181: The research measured up to four blood biomarkers linked to neurodegeneration. After adjusting for kidney function, associations for three of those markers disappeared. Only p-tau181 remained robustly linked to long sleep, highlighting its specificity as an Alzheimer’s-related indicator.
- Robust adjustment for confounders: The non-linear association persisted after controlling for multiple potential confounders, including age, sex, clinical sleep apnea, depression, kidney function, and the apolipoprotein E ε4 genotype.
- Behavioral marker, not proof of causation: Because this is a cross-sectional study, the authors emphasize that long sleep should be viewed as a possible downstream behavioral footprint of early neurodegenerative processes—not a proven cause of Alzheimer’s disease.
- Clinical relevance: The practical takeaway is straightforward: older adults who consistently require nine to ten hours or more of sleep to feel rested should consider discussing sleep quality and brain health with their clinician. Extended sleep could serve as a useful prompt for further assessment and monitoring.
Source: UT Health San Antonio
Regularly sleeping long hours each night is associated with higher levels of an Alzheimer’s-related protein in the blood, even after accounting for other health factors, according to a new study from UT Health San Antonio, the academic health center of The University of Texas at San Antonio.
In an analysis of 2,410 participants, researchers found a significant link between self-reported sleep duration and plasma phosphorylated tau 181 (p-tau181), a modified form of tau protein that is a central biomarker for Alzheimer’s disease and can now be detected in blood samples.
The analysis showed that sleep durations starting at about eight-and-a-half to nine hours per night were associated with higher p-tau181 concentrations, with the strongest increases observed beyond ten hours. These patterns suggest that long sleep may reflect early neurodegenerative processes rather than being a direct cause of disease.
“Many people wonder how their sleep patterns relate to brain health,” said Vanessa M. Young, PhD, MS, a postdoctoral research fellow at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio and the study’s first author.
“Because this work captures a single point in time, it cannot establish causation. But the association we observed suggests that more sleep is not necessarily better for brain health and that persistent long sleep may be worth monitoring by clinicians.”
Young, also a trainee at the Sam and Ann Barshop Institute for Longevity and Aging Studies, led the study titled “Non-linear associations between sleep duration and plasma p-tau181 in the Framingham Heart Study,” published May 19 in Alzheimer’s & Dementia, the Journal of the Alzheimer’s Association.
Participants came from the Framingham Heart Study, a long-running community cohort in Framingham, Massachusetts. Their mean age was about 70 years (± 8.45 years) and 55.2% were female. This analysis builds on earlier work from 2025 showing links between very long sleep and poorer cognitive performance, especially among people with depression, but extends those findings by examining blood-based biomarkers with rigorous statistical controls.
The long and short of it
Both short and long sleep have been associated with Alzheimer’s risk in prior studies, but the specific shape of that relationship—how risk changes across different sleep durations—has been understudied. Non-linear modeling accounts for relationships that do not follow a straight line: effects can change direction or intensity at different levels of the predictor variable.
The research team applied restricted cubic splines (RCS) to model the relationship between self-reported sleep duration and four plasma biomarkers: p-tau181, total tau, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP). The RCS approach revealed a distinct non-linear association with p-tau181, showing higher levels beginning at about 8.5 hours of sleep and increasing steeply after 10 hours, even when accounting for age, sex, APOE ε4 status, sleep apnea, depression, and kidney function.
When the investigators adjusted for kidney function, associations between sleep duration and three other biomarkers disappeared, indicating those elevations were likely driven by reduced filtration rather than brain-specific processes. Only p-tau181 remained associated with long sleep after these controls, supporting the notion that the link is specific to Alzheimer’s-related pathways.
The authors conclude that long sleep may serve as a behavioral marker of elevated plasma p-tau181 and recommend prospective longitudinal studies to determine the temporal sequence and underlying mechanisms. In clinical terms, routinely needing nine to ten or more hours of sleep to feel rested can be a useful conversation starter with a healthcare provider about sleep quality, biomarker screening, and proactive brain-health monitoring.
Key Questions Answered:
A: A non-linear relationship allows the association between sleep and biomarkers to change across different sleep amounts rather than assuming a constant rate of change. Using restricted cubic splines let the investigators detect a flat relationship at typical sleep durations but a clear upward turn beginning around 8.5 hours—an important pattern that linear models would miss.
A: No. The study does not show that long sleep causes Alzheimer’s, and deliberately cutting back sleep is not a recommended strategy to reduce risk. Rather, persistent long sleep may be a symptom of early brain changes. If long sleep is unusual or concerning, consult a clinician to evaluate sleep quality and overall health.
A: Kidneys filter proteins from the blood. Reduced kidney function can cause elevations in blood biomarkers that are unrelated to brain pathology. Accounting for kidney function removed apparent associations for three biomarkers, leaving p-tau181 as the marker most likely reflecting Alzheimer’s-related processes rather than filtration issues.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full for accuracy.
- Additional context was added by editorial staff.
About this Alzheimer’s disease and sleep research news
Author: Steven Lee
Source: UT Health San Antonio
Contact: Steven Lee – UT Health San Antonio
Image: Photo credit: Neuroscience News
Original Research: Open access. “Non-linear associations between sleep duration and plasma p-tau181 in the Framingham Heart Study” by Vanessa M. Young et al., published in Alzheimer’s & Dementia. DOI: 10.1002/alz.71499
Abstract
Non-linear associations between sleep duration and plasma p-tau181 in the Framingham Heart Study
INTRODUCTION
Both short and long sleep durations have been linked to Alzheimer’s disease risk, but the detailed, non-linear relationships between sleep quantity and blood-based biomarkers of Alzheimer’s and neurodegeneration remain underexplored.
METHODS
Among 2,410 Framingham Heart Study participants (mean age 70.0 ± 8.45 years; 55.2% female), the investigators examined associations between self-reported sleep duration and plasma p-tau181, total tau, neurofilament light chain, and glial fibrillary acidic protein using restricted cubic splines and categorical comparisons (≤ 6 hours, > 6–< 9 hours reference, ≥ 9 hours).
RESULTS
Restricted cubic spline models revealed non-linear associations between sleep duration and p-tau181 (overall p = 0.005; non-linearity p = 0.002), with higher p-tau181 at ≥ 8.5 hours after adjusting for age, sex, APOE ε4 genotype, sleep apnea, depression, and kidney function. Categorical comparisons did not show associations in fully adjusted models.
DISCUSSION
Sleep duration shows a robust non-linear relationship with plasma p-tau181. These results emphasize the value of non-linear modeling when studying sleep and blood-based Alzheimer’s biomarkers. Longitudinal research is needed to determine temporal sequences and underlying mechanisms.